Target High-Growth Returns in the $5.6 Trillion Wellness Revolution

with NASA-Designed "Biohacking" Technology.

Discover how Quelliv is scaling to 350+ locations and a projected 2026 Direct Listing IPO by leveraging proprietary biophotonic tech endorsed by the world’s leading performance experts.

(This means you earn $200K+ individually, $300K+ jointly, or have $1M+ in assets, excluding your primary residence.) *

Wellness Investment

  • Defined roadmap for a liquidity event.

  • 4 successful beta sites in South Florida.

  • Proprietary SLD tech with a massive competitive moat

  • Led by veterans in tech and retail scaling

  • Built for the $5.6 Trillion wellness sector

For accredited investors only. Interests in Blue Capital Fund LLC are offered under Rule 506(c) of Regulation D by confidential Private Placement Memorandum (PPM) and related documents. These unregistered securities are speculative, illiquid, and may result in total loss of capital. Distributions and return targets are forward-looking estimates, not guarantees; past performance does not predict future results. Nothing herein constitutes investment, tax, legal, or accounting advice. Investors must rely on their own professional advisers. Neither the SEC nor any state regulator has approved or disapproved these securities.

Copyright 2026 | Quelliv Inc | Terms & Conditions